Urinary gonadotropin peptide levels in preeclamptic and normotensive pregnant women. Results from a pilot case-control study

Gynecologic and Obstetric Investigation

Volumn 45, Issue 1, 1998, Pages 24-28

  Williams, Michelle A ^a,c   Luthy, David A ^a   Zingheim, Rosalee W ^a   Zebelman, Arthur M ^b   Sorensen, Tanya K ^a   Resta, Robert G ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b DYNACARE LABORATORIES   (Canada)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Preeclampsia; Pregnancy; Urinary gonadotropin peptide

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; GONADOTROPIN;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DILUTION; DISEASE MARKER; DOWN SYNDROME; ENZYME IMMUNOASSAY; FEMALE; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HUMAN; MOTHER FETUS RELATIONSHIP; PLACENTA PERFUSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS; THIRD TRIMESTER PREGNANCY; URINALYSIS;

ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; FEMALE; HUMANS; PEPTIDE FRAGMENTS; PILOT PROJECTS; PRE-ECLAMPSIA; PREGNANCY; REFERENCE VALUES;

EID: 0031973606     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000009918     Document Type: Article

References (27)

1. Zuspan FP, Samules P: Preventing preeclampsia. N Engl J Med 1993;329:1265-1266.
2. De Wolf F, Robertson WB, Brosens I: The ultrastructure of acute atherosclerosis in hypertensive pregnancy. Am J Obstet Gynecol 1975;123:164-174.
3. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin MK: Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol 1989;161:1025-1034.
4. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK: Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-1204.
5. Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC, Roberts JM: High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 1991;165:895-901.
6. Walsh SW: Lipid peroxidation in pregnancy. Hypertens Pregnancy 1994;13:1-32.
7. Wang Y, Walsh SW, Kay HH: Placental lipid peroxides and thromboxane are both increased and prostacyclin decreased in women with preeclampsia. Am J Obstet Gynecol 1992;176:946-949.
8. Jendryoczko A, Drozdz M: Plasma retinol, β-carotene and vitamin E levels in relation to the future risk of preeclampsia. Zentralbl Gynäkol 1989;111:1121-1123.
9. Potter JM, Nestel PJ: The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979;133:165-170.
10. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M: The association between unex-plained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992;80:83-86.
11. Sorensen TK, Williams MA, Zingheim RW, Clement SJ, Hickok DE: Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol 1993;169:834-838.
12. Gravett CP, Buckmaster JG, Watson PT, Gravett MG: Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome. Am J Med Genet 1992;44:485-486.
13. Cuckle HS, Iles RK, Chard T: Urinary β-core human chorionic gonadotropin: A new approach to Down's syndrome screening. Prenat Diagn 1994;14:953-958.
14. Hayashi M, Kozu H: Maternal urinary β-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy. Prenat Diagn 1995;15:11-16.
15. Canick JA, Kellner LH, Saller DN Jr, Palomaki GE, Walker RP, Osathnondh R: Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy. Prenat Diagn 1995;15:739-744.
16. Pritchard JA, MacDonald PC, Gant NF: Williams Obstetrics, ed 17. Norwalk, Appleton-Century-Crofts, 1985, pp 525-529.
17. American College of Obstetricians and Gynecologists. Management of Preeclampsia. Tech Bull No 19, 1986.
18. Faiman C: Gonadotropins during pregnancy and the puerperium; in Goodwin JW, Godden JO, Chance GW (eds): Perinatal Medicine: The Basic Science Underlying Clinical Practice. Baltimore, Williams & Wilkins, 1976, pp 330-335.
19. Hay DL: Placental histology and the production of human choriogonadotrophin and its subunits in pregnancy. Br J Obstet Gynaecol 1988;95:1268-1275.
20. Hamilton WJ, Hamilton DV: Development of the human placenta; in Phillip EE, Barnes J, Newton M (eds): Scientific Foundations of Obstetrics and Gynaecology. London, Heinemann Medical, 1977, pp 292-358.
21. Lieppman RE, Williams MA, Cheng EY, Resta RG, Zingheim R, Hickok DE, Luthy DA: An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcomes. Am J Obstet Gynecol 1993;168:1852-1857.
22. Teoh ES, Sivasamboo MB: Immunological chorionic gonadotrophin titers in severe toxemia of pregnancy. J Obstet Gynaecol Br Commonw 1968;75:724-727.
23. Fox H: Effect of hypoxemia on trophoblasts in organ culture: A morphologic and autoradiographic study. Am J Obstet Gynecol 1970;107:1058-1064.
24. Blithe DL, Akar AH, Wehmann RE, Nisula BC: Purification of β-core fragment from pregnancy urine and demonstration that its carbohydrate moieties differ from those of native human chorionoic gonadotropin. Endocrinology 1988;122:173-180.
25. Wehmann RE, Blithe DL, Akar AH, Nisula BC: Disparity between β-core levels in pregnancy urine and serum: Implications for the origin of urinary β-core. J Clin Endocrinol Metab 1990;70:371-378.
26. Nisula BC, Blithe DL, Akar A, Laport G, Wehmann RE: Metabolic fate of human choriogon-adotropin. J Steroid Biochem 1989;33:733-737.
27. Cole LA, Kardana A, Park SY, Braunstein GD: The deactivation of hCG by nicking and dissociation. J Clin Endocrinol Metab 1993;76:704-710.